149 related articles for article (PubMed ID: 17614734)
1. Fluorescence and absorption assessment of a lipid mTHPC formulation following topical application in a non-melanotic skin tumor model.
Johansson A; Svensson J; Bendsoe N; Svanberg K; Alexandratou E; Kyriazi M; Yova D; Gräfe S; Trebst T; Andersson-Engels S
J Biomed Opt; 2007; 12(3):034026. PubMed ID: 17614734
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence monitoring of a topically applied liposomal Temoporfin formulation and photodynamic therapy of nonpigmented skin malignancies.
Bendsoe N; Persson L; Johansson A; Axelsson J; Svensson J; Gräfe S; Trebst T; Andersson-Engels S; Svanberg S; Svanberg K
J Environ Pathol Toxicol Oncol; 2007; 26(2):117-26. PubMed ID: 17725537
[TBL] [Abstract][Full Text] [Related]
3. Tumor selectivity at short times following systemic administration of a liposomal temoporfin formulation in a murine tumor model.
Svensson J; Johansson A; Gräfe S; Gitter B; Trebst T; Bendsoe N; Andersson-Engels S; Svanberg K
Photochem Photobiol; 2007; 83(5):1211-9. PubMed ID: 17880517
[TBL] [Abstract][Full Text] [Related]
4. Topical application of temoporfin-loaded invasomes for photodynamic therapy of subcutaneously implanted tumours in mice: a pilot study.
Dragicevic-Curic N; Gräfe S; Albrecht V; Fahr A
J Photochem Photobiol B; 2008 Apr; 91(1):41-50. PubMed ID: 18316200
[TBL] [Abstract][Full Text] [Related]
5. Localization of liposomal mTHPC formulations within normal epithelium, dysplastic tissue, and carcinoma of oral epithelium in the 4NQO-carcinogenesis rat model.
de Visscher SA; Witjes MJ; van der Vegt B; de Bruijn HS; van der Ploeg-van den Heuvel A; Amelink A; Sterenborg HJ; Roodenburg JL; Robinson DJ
Lasers Surg Med; 2013 Dec; 45(10):668-78. PubMed ID: 24174342
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of temoporfin-loaded invasomes in the photodynamic therapy in human epidermoid and colorectal tumour cell lines.
Dragicevic-Curic N; Gräfe S; Gitter B; Fahr A
J Photochem Photobiol B; 2010 Dec; 101(3):238-50. PubMed ID: 20797872
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and biodistribution study following systemic administration of Fospeg®--a Pegylated liposomal mTHPC formulation in a murine model.
Xie H; Svenmarker P; Axelsson J; Gräfe S; Kyriazi M; Bendsoe N; Andersson-Engels S; Svanberg K
J Biophotonics; 2015 Jan; 8(1-2):142-52. PubMed ID: 24375973
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with intratumoral administration of Lipid-Based mTHPC in a model of breast cancer recurrence.
D'Hallewin MA; Kochetkov D; Viry-Babel Y; Leroux A; Werkmeister E; Dumas D; Gräfe S; Zorin V; Guillemin F; Bezdetnaya L
Lasers Surg Med; 2008 Oct; 40(8):543-9. PubMed ID: 18798287
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements.
Glanzmann T; Forrer M; Blant SA; Woodtli A; Grosjean P; Braichotte D; van den Bergh H; Monnier P; Wagnières G
J Photochem Photobiol B; 2000 Aug; 57(1):22-32. PubMed ID: 11100834
[TBL] [Abstract][Full Text] [Related]
10. Determination of the maximal carcinoma/normal skin ratio after HpD or m-THPC administration in Hairless mice (SKH-1) by fluorescence spectroscopy.
Bossu E; Padilla-Ybarra JJ; Notter D; Vigneron C; Guillemin F
Anticancer Drugs; 2000 Feb; 11(2):85-91. PubMed ID: 10789590
[TBL] [Abstract][Full Text] [Related]
11. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
12. Liposomes in topical photodynamic therapy.
Dragicevic-Curic N; Fahr A
Expert Opin Drug Deliv; 2012 Aug; 9(8):1015-32. PubMed ID: 22731896
[TBL] [Abstract][Full Text] [Related]
13. Influence of incubation time and sensitizer localization on meta-tetra(hydroxyphenyl)chlorin (mTHPC)-induced photoinactivation of cells.
Sasnouski S; Pic E; Dumas D; Zorin V; D'Hallewin MA; Guillemin F; Bezdetnaya L
Radiat Res; 2007 Aug; 168(2):209-17. PubMed ID: 17638401
[TBL] [Abstract][Full Text] [Related]
14. Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC.
Lassalle HP; Dumas D; Gräfe S; D'Hallewin MA; Guillemin F; Bezdetnaya L
J Control Release; 2009 Mar; 134(2):118-24. PubMed ID: 19100297
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours.
Boiy A; Roelandts R; de Witte PA
J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men.
Triesscheijn M; Ruevekamp M; Out R; Van Berkel TJ; Schellens J; Baas P; Stewart FA
Cancer Chemother Pharmacol; 2007 Jun; 60(1):113-22. PubMed ID: 17009028
[TBL] [Abstract][Full Text] [Related]
17. Macrophage selective photodynamic therapy by meta-tetra(hydroxyphenyl)chlorin loaded polymeric micelles: A possible treatment for cardiovascular diseases.
Wennink JWH; Liu Y; Mäkinen PI; Setaro F; de la Escosura A; Bourajjaj M; Lappalainen JP; Holappa LP; van den Dikkenberg JB; Al Fartousi M; Trohopoulos PN; Ylä-Herttuala S; Torres T; Hennink WE; van Nostrum CF
Eur J Pharm Sci; 2017 Sep; 107():112-125. PubMed ID: 28679107
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy with meso-tetra(hydroxyphenyl) chlorin in the topical treatment of Bowen's disease and basal cell carcinoma.
Gupta G; Morton CA; Whitehurst C; Moore JV; MacKie RM
Br J Dermatol; 1999 Aug; 141(2):385-6. PubMed ID: 10468840
[No Abstract] [Full Text] [Related]
19. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution of the photosensitizer temoporfin after in vivo topical application of temoporfin-loaded invasomes in mice bearing subcutaneously implanted HT29 tumor.
Dragicevic N; Nikolic B; Albrecht V; Fahr A
Int J Pharm; 2022 Dec; 629():122374. PubMed ID: 36351505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
